The Effect of Vision-Related Quality of Life on Depression and Anxiety in Patients with Behçet Uveitis

The Effect of Vision-Related Quality of Life on Depression and Anxiety in Patients with Behçet Uveitis

Objectives:To evaluate the effect of vision-related quality of life on depression and anxiety in patients with Behçet uveitis.Materials and Methods:The Beck Depression Inventory (BDI), the State-Trait Anxiety Inventory (STAI) I-II, and the Visual Functioning Questionnaire (VFQ)-25 were used to evalu...

Full description

Bibliographic Details
Main Authors:	Hilal Eser-Öztürk, Volkan Yeter, Aytül Karabekiroğlu, Yüksel Süllü
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2021-12-01
Series:	Türk Oftalmoloji Dergisi
Subjects:	behçet uveitis depression anxiety disorder vision-related quality of life
Online Access:	http://www.oftalmoloji.org/archives/archive-detail/article-preview/the-effect-of-vision-related-quality-of-life-on-de/50642

Similar Items

Vitreomacular Interface Disorders in Behçet’s Uveitis
by: Hilal Eser Öztürk, et al.
Published: (2017-12-01)

Pattern and Visual Prognostic Factors of Behcet’s Uveitis in Northwest Iran
by: Leila Alizadeh Ghavidel, et al.
Published: (2022-05-01)

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
by: F. Nilüfer Yalçındağ, et al.
Published: (2021-08-01)

Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study
by: Masaru Takeuchi, et al.
Published: (2023-01-01)

Behçet’s Uveitis: Current Diagnostic and Therapeutic Approach
by: Pınar Çakar Özdal
Published: (2020-06-01)

Behçet’s Disease Uveitis
by: Morgane Joubert, et al.
Published: (2023-05-01)

Features of systemic cytokine production in Behcet's disease associated with uveitis without ocular lesions
by: E. S. Sorozhkina, et al.
Published: (2021-11-01)

Interferon alpha-2a treatment for refractory Behcet uveitis in Korean patients
by: Ji Hwan Lee, et al.
Published: (2018-02-01)

Behçet uveitis: Current practice and future perspectives
by: Shereen H. Aboul Naga, et al.
Published: (2022-09-01)

Risk of anxiety and depression in patients with uveitis: a Meta-analysis
by: Bei Cui, et al.
Published: (2022-08-01)

Early administration of adalimumab for paediatric uveitis due to Behçet’s disease
by: Tomona Hiyama, et al.
Published: (2019-06-01)

Cataract surgery combined with micro-incision vitrectomy in patients with behcet’s disease uveitis
by: Fang Fan, et al.
Published: (2018-06-01)

Conventional immunosuppressive therapy in severe Behcet’s Uveitis: the switch rate to the biological agents
by: Hande Celiker, et al.
Published: (2018-10-01)

High Sensitive CRP in Behcet Disease With and Without Uveitis Compared With Idiopathic Uveitis: A Cross-Sectional Study
by: Maryam Sahebari, et al.
Published: (2017-10-01)

Uveitis developing in tuberculous lymphadenitis‐associated Behçet's disease during anti‐tuberculosis therapy
by: Saeko Takahashi, et al.
Published: (2020-08-01)

Behçet disease
by: Ioan Buraga, et al.
Published: (2010-09-01)

Ocular Manifestations of Behçet’s Disease: An Update on Diagnostic Challenges and Disease Management
by: Hanna Zając, et al.
Published: (2021-11-01)

Clinical heterogeneity of ocular Behçet’s syndrome versus intestinal Behçet’s syndrome: a cross-sectional study from Shanghai Behçet’s syndrome database
by: Cheng-cheng Hou, et al.
Published: (2022-04-01)

Vascular Abnormalities in Peripapillary and Macular Regions of Behcet's Uveitis Patients Evaluated by Optical Coherence Tomography Angiography
by: Chun Yan, et al.
Published: (2021-09-01)

Old and New Challenges in Uveitis Associated with Behçet’s Disease
by: Julie Gueudry, et al.
Published: (2021-05-01)

Comparative effectiveness of various immunosuppressive therapy regimens for uveitis in patients with Behçet’s disease
by: T. A. Lisitsyna, et al.
Published: (2021-05-01)

Twenty Years of Quiescence after Nonstop Remicade® (Infliximab) Infusions in a Child with Ocular Behçet Disease Presenting as Hypopyon-Anterior Uveitis Refractory to Immunosuppressants
by: Cem Evereklioglu
Published: (2023-02-01)

Evaluation of Serum Homocysteine and Leptin Levels in Patients with Uveitis
by: Arif Emre Elbay, et al.
Published: (2015-08-01)

Serum KL-6 elevation in a uveitis patient with Behçet's disease treated with adalimumab
by: Takashi Ono, et al.
Published: (2020-06-01)

Assessment of sleep quality, anxiety, depression, and quality of life in Behçet’s disease
by: Ahmad M. Shaddad, et al.
Published: (2023-05-01)

Profiling tear proteomes of patients with unilateral relapsed Behcet’s disease-associated uveitis using data-independent acquisition proteomics
by: Anyi Liang, et al.
Published: (2020-06-01)

Half-fluence Photodynamic Therapy for Central Serous Chorioretinopathy in a Patient Receiving Corticosteroids for Behçet’s Uveitis
by: Hüseyin Baran Özdemir, et al.
Published: (2022-04-01)

Effects of anti-TNF biologic drugs on uveitis severity in Behcet patients: systematic review and Meta-analysis
by: Somayeh Abolhasani, et al.
Published: (2022-05-01)

Celiac Disease Antibody Frequency in Idiopathic Uveitis Patients
by: Rıdvan Mercan
Published: (2017-07-01)

The intraocular CD4/CD8 ratio in a black South African patient with Behçet’s disease uveitis
by: A Makgotloe
Published: (2017-01-01)

Infliximabe no tratamento de uveíte posterior refratária em paciente com doença de Behçet Infliximab treatment for refractory posterior uveitis in Behçet's disease
by: Sinara da Silva Freitas, et al.
Published: (2005-04-01)

EFFECT OF HUMAN HERPES VIRUS REACTIVATION ON SYSTEMIC CYTOKINE PRODUCTION IN PATIENTS WITH BEHCET’S DISEASE AND UVEITIS
by: G. I. Krichevskaya, et al.
Published: (2021-10-01)

Pediatric Uveitis
by: Ilknur Tugal-Tutkun
Published: (2011-01-01)

Evaluation of uveitis activity in Behcet's disease patients using BOS24
by: V. V. Neroev, et al.
Published: (2018-10-01)

Patterns of uveitis at a tertiary referral center in Northeastern Iran
by: Seyedeh Maryam Hosseini, et al.
Published: (2018-01-01)

Changing pattern of clinical manifestations of Behçet’s disease in Tunisia: comparison between two decades
by: Imen Ksiaa, et al.
Published: (2020-04-01)

Advances in pathogenesis and treatment of ocular involvement in Behcet’s disease
by: Suibin Lin, et al.
Published: (2023-09-01)

Shaping the Future of Behçet’s Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies
by: Biao Li, et al.
Published: (2023-07-01)

Uveitis-induced Refractory Ocular Hypotony Managed with High-dose Latanoprost
by: Fariba Ghassemi, et al.
Published: (2020-08-01)

Clinical profile and management with immunosuppressants and biologics in Behcet's uveitis: A cohort of 25 patients from a tertiary eye care center in South India
by: Jeyasooriya Ramdoss, et al.
Published: (2023-01-01)